Review on Substituted Chalcones

References

[1] V. Kostanecki, S., & Tambor, J. (1899). Ueber die sechsisomerenMonooxybenzalacetophenone (Monooxychalkone). Berichte der deutschenchemischen Gesellschaft, 32(2), 1921-1926.

[2] Rice-Evans, C. (2001). Flavonoid antioxidants. Current medicinal chemistry, 8(7), 797-807.

[3] Seitz, C., Eder, C., Deiml, B., Kellner, S., Martens, S., &Forkmann, G. (2006). Cloning, functional identification and sequence analysis of flavonoid 3′-hydroxylase and flavonoid 3′, 5′-hydroxylase cDNAs reveals independent evolution of flavonoid 3′, 5′-hydroxylase in the Asteraceae family. Plant molecular biology, 61, 365-381.

[4] Pękal, A., &Pyrzynska, K. (2014). Evaluation of aluminium complexation reaction for flavonoid content assay. Food Analytical Methods, 7, 1776-1782.

[5] Dziedzic, S. Z., & Hudson, B. J. (1983). Polyhydroxy chalcones and flavanones as antioxidants for edible oils. Food Chemistry, 12(3), 205-212.

[6] Pistelli, L., Spera, K., Flamini, G., Mele, S., & Morelli, I. (1996). Isoflavonoids and chalcones from Anthyllis hermanniae. Phytochemistry, 42(5), 1455-1458.

[7] Singh, P. K., &Silakari, O. (2018). The current status of O‐heterocycles: A synthetic and medicinal overview. ChemMedChem, 13(11), 1071-1087.

[8] Meanwell, N. A. (2017). A synopsis of the properties and applications of heteroaromatic rings in medicinal chemistry. In Advances in Heterocyclic Chemistry (Vol. 123, pp. 245-361). Academic Press.

[9] De, A., Sarkar, S., &Majee, A. (2021). Recent advances in heterocyclic compounds with antiviral properties. Chemistry of Heterocyclic Compounds, 57(4), 410-416.

[10] Xu, M., Wu, P., Shen, F., Ji, J., & Rakesh, K. P. (2019). Chalcone derivatives and their antibacterial activities: Current development. Bioorganic Chemistry, 91, 103133.

[11] Mellado, M., Espinoza, L., Madrid, A., Mella, J., Chávez-Weisser, E., Diaz, K., & Cuellar, M. (2020). Design, synthesis, antifungal activity, and structure–activity relationship studies of chalcones and hybrid dihydrochromane–chalcones. Molecular diversity, 24, 603-615.

[12] Cheng, P., Yang, L., Huang, X., Wang, X., & Gong, M. (2020). Chalcone hybrids and their antimalarial activity. Archiv der Pharmazie, 353(4), 1900350.

[13] Elkhalifa, D., Al-Hashimi, I., Al Moustafa, A. E., & Khalil, A. (2021). A comprehensive review on the antiviral activities of chalcones. Journal of Drug Targeting, 29(4), 403-419.

[14] Ventura, T. L. B., Calixto, S. D., Abrahim-Vieira, B. D. A., Souza, A. M. T. D., Mello, M. V. P., Rodrigues, C. R., ... &Muzitano, M. F. (2015). Antimycobacterial and anti-inflammatory activities of substituted chalcones focusing on an anti-tuberculosis dual treatment approach. Molecules, 20(5), 8072-8093.

[15] Zheoat, A. M., Alenezi, S., Elmahallawy, E. K., Ungogo, M. A., Alghamdi, A. H., Watson, D. G., ... & Ferro, V. A. (2021). Antitrypanosomal and antileishmanial activity of chalcones and flavanones from Polygonum salicifolium. Pathogens, 10(2), 175.

[16] Tajuddeen, N., Isah, M. B., Suleiman, M. A., van Heerden, F. R., & Ibrahim, M. A. (2018). The chemotherapeutic potential of chalcones against leishmaniases: a review. International journal of antimicrobial agents, 51(3), 311-318.

[17] Sharma, R., Kumar, R., Kodwani, R., Kapoor, S., Khare, A., Bansal, R., ... & Kumar, S. (2016). A review on mechanisms of anti-tumor activity of chalcones. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 16(2), 200-211.

[18] Karthikeyan, C., SH Narayana Moorthy, N., Ramasamy, S., Vanam, U., Manivannan, E., Karunagaran, D., & Trivedi, P. (2015). Advances in chalcones with anticancer activities. Recent patents on anti-cancer drug discovery, 10(1), 97-115.

[19] Shaik, A., Bhandare, R. R., Palleapati, K., Nissankararao, S., Kancharlapalli, V., & Shaik, S. (2020). Antimicrobial, antioxidant, and anticancer activities of some novel isoxazole ring containing chalcone and dihydropyrazole derivatives. Molecules, 25(5), 1047.

[20] Miyazawa, M., Kakiuchi, A., Watanabe, H., & Kameoka, H. (1998). Inhibition of acetylcholinesterase activity by volatile α, β-unsaturated ketones. Natural Product Letters, 12(2), 131-134.

[21] Ahmad, A., Sinha, R. K., Kulkarni, S. D., Lewis, P. M., Bhat, P., & Shetty, N. S. (2023). Synthesis, photophysical properties and DFT studies of chalcones and their 2-methoxy-3-cyanopyridine derivatives. Journal of Photochemistry and Photobiology A: Chemistry, 437, 114494.

[22] Sharma, S., Kaur, S., Bansal, T., & Gaba, J. (2014). Review on synthesis of bioactive pyrazoline derivatives. Chem Sci Trans, 3(3), 861-875.

[23] Sunitha, V., Kumar, A. K., Mahesh, M., Shankaraiah, P., Jalapathi, P., & Lincoln, C. A. (2018). Synthesis and antimicrobial evaluation of Bis-3, 5-disubstituted isoxazoles based chalcones. Russian Journal of General Chemistry, 88, 1904-1911.

[24] Farooq, S., &Ngaini, Z. (2021). One‐pot and two‐pot methods for chalcone derived pyrimidines synthesis and applications. Journal of Heterocyclic Chemistry, 58(6), 1209-1224.

[25] Kesari, C., Rama, K. R., Sedighi, K., Stenvang, J., Björkling, F., Kankala, S., & Thota, N. (2021). Synthesis of thiazole linked chalcones and their pyrimidine analogues as anticancer agents. Synthetic Communications, 51(9), 1406-1416.

[26] Jioui, I., Dânoun, K., Solhy, A., Jouiad, M., Zahouily, M., Essaid, B., ... & Fihri, A. (2016). Modified fluorapatite as highly efficient catalyst for the synthesis of chalcones via Claisen–Schmidt condensation reaction. Journal of Industrial and Engineering Chemistry, 39, 218-225.

[27] Tiecco, M., Germani, R., &Cardellini, F. (2016). Carbon–carbon bond formation in acid deep eutectic solvent: chalcones synthesis via Claisen–Schmidt reaction. RSC advances, 6(49), 43740-43747.

[28] Tamuli, K. J., Sahoo, R. K., & Bordoloi, M. (2020). Biocatalytic green alternative to existing hazardous reaction media: synthesis of chalcone and flavone derivatives via the Claisen–Schmidt reaction at room temperature. New Journal of Chemistry, 44(48), 20956-20965.

[29] Bentahar, S., Taleb, M. A., Sabour, A., Dbik, A., Khomri, M. E., Messaoudi, N. E., &Lacherai, A. (2020). The use of modified clay as an efficient heterogeneous and ecofriendly catalyst for the synthesis of chalcones via Claisen-Schmidt condensation. Russian Journal of Applied Chemistry, 93, 983-990.

[30] Mazza, L. J., & Guarna, A. (1980). An improved synthesis of 1, 3-diphenyl-2-buten-1-ones (β-methylchalcones). Synthesis, 1980(01), 41-44.

[31] Szell and Sipos, Ann. 64, 113 (1961)

[32] C. Kuroda, T. Matsukuma, Chem Abstr. 26, 2442 (1932)

[33] Kohler, E. P., & Chadwell, H. M. (2003). Benzalacetophenone: chalcone. Organic syntheses, 2, 1-1.

[34] Schraufstätter, E., & Deutsch, S. (1948). ÜberChalkone, I. Mitteil.: Zur Darstellung von Chalkonen. ChemischeBerichte, 81(6), 489-499.

[35] . H.E. Smith, M.C. Paulson, J. Am. Chem. Soc. 76, 4486 (1954)

[36] H. Obara, J. Onodera, Y. Kurihara, Bull. Chem. Soc. Jpn. 44, 289 (1971)

[37] DHAR, D. N., & LAL, J. B. (1958). Chalcones. Condensation of aromatic aldehydes with resacetophenone. II. The Journal of Organic Chemistry, 23(8), 1159-1161.

[38] R.T. Morrison, R.N. Boyd, Organic Chemistry, 6th edn. (Pearson Education Publishers, 2004), pp. 971–990, 997–1020

[39] S.M. Mukherji, S.P. Singh, R.P. Kapoor, Organic Chemistry, vol. II. (New Age International (P) Limited Publishers, 2003), pp. 586–587

[40] A. Bianco, C. Cavarischia, A. Farina, M. Guiso, C.A. Marra, Tetrahedron Lett. 44(51), 9107–9109 (2003)

[41] Venkataraman, V. R., & Nagarajan, S. (1986). Synthesis of New Isomeric Chalcones. ChemischerInformationsdienst, 17(34).

[42] Bestmann, H. J., & Arnason, B. (1962). ReaktionenmitPhosphin‐alkylenen, II. C‐Acylierung von Phosphin‐alkylenen. Ein neuer Weg zurSynthese von Ketonen. ChemischeBerichte, 95(6), 1513-1527.

[43] I. Abe, Y. Sano, Y. Takahashi, H. Noguchi, J. Biol. Chem. 278(27), 25218–25226 (2003)

[44] T. Baba, H. Kizuka, H. Handa, Y. Ono, Appl Catal. 194–195, 203 (2000)

[45] W. Wei, W. Qunrong, D. Liqin, Z. Aiquing, W. Duoyauan, Ultrasonics Sonochem. 12(6), 411–414 (2005)

[46] A. Fuentes, J.M. Marinas, J.V. Sinisterra, Tetrahedron Lett. 28(39), 4541–4544 (1987)

[47] G. Rothenberg, A.P. Downie, C.L. Raston, J.L. Scott, J. Am. Chem. Soc. 123, 8701–8708 (2001)

[48] U.C. Rajesh, G. Purohit, D.S. Rawat, ACS Sustain. Chem. Eng. 3(10), 2397–2404 (2015)

@article{1705321,
      author = {Jaywant Kolambe, Dr. Yogita Shinde, Dr. Kalpana Patankar Jain, Dr. Gunwanti Sinwal},
      title = {Review on Substituted Chalcones},
      journal = {Iconic Research And Engineering Journals},
      year = {2023},
      volume = {7},
      number = {6},
      pages = {246-252},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/17053212.pdf},
      abstract = {Chalcones and their analogues have emerged as a subject of significant attention in contemporary times. A multitude of scholarly articles have been disseminated, attesting to the ongoing potential of chalcones in the realm of novel pharmaceutical inquiries. Scholars have conducted investigations into novel methodologies for the production of chalcone derivatives, leading to the discovery of a diverse range of pharmacological and biological impacts. The chalcone derivatives have demonstrated significant capabilities in various areas, including antimicrobial, antifungal, anti-mycobacterial, antimalarial, antiviral, anti-inflammatory, antioxidant, antileishmanial, anti-tumour, and anticancer activities. The present paper provides an overview of the production and pharmacological characteristics of chalcone derivatives.},
      keywords = {Chalcone, Synthesis, Pharmacological properties},
      month = {December},
  }